Results 101 to 110 of about 747 (150)

[Challenges on off label medicine use]. [PDF]

Rev Paul Pediatr, 2016
Lima Carvalho M.
europepmc   +1 more source

[Preventive activities in women's care]. [PDF]

Aten Primaria, 2020
López García-Franco A, Baeyens Fernández JA, Bailón Muñoz E, Iglesias Piñeiro MJ, Ortega Del Moral A, Coello PA, Ruiz Cabello C, Landa Goñi J, Arribas Mir L, Grupo de la Mujer del PAPPS.   +9 more
europepmc   +1 more source

TALIDOMIDA EM PACIENTE COM SÍNDROME 5Q-: UM RELATO DE CASO

, 2020
J. Júnior, M. Moura, P. Azevedo
semanticscholar   +1 more source

TERAPIA DE MANUTENÇÃO NO MIELOMA MÚLTIPLO: IMPACTO DO USO DE TALIDOMIDA SOBRE A NECESSIDADE DE NOVA TERAPIA (NNT)

, 2020
C. Liz, W. M. Braga
semanticscholar   +1 more source

[Adverse drug reactions and letters to the editor]. [PDF]

Aten Primaria, 2009
Garcia Llopis P, Martínez-Mir I, Palop Larrea V.   +2 more
europepmc   +1 more source

[Current Concepts and Approach to Mid-Gastrointestinal Bleeding]. [PDF]

Acta Gastroenterol Latinoam
Giraudo F, Garbi ML.
europepmc   +1 more source

[New drugs policy: safety and quality]. [PDF]

Aten Primaria, 2011
Amado Guirado E, Diego L, Madridejos Mora R.   +2 more
europepmc   +1 more source

Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024. [PDF]

Epidemiol Serv Saude
Silva SN, Saliba MF, Ribeiro LR, Cota G.
europepmc   +1 more source

Hematological approaches to multiple myeloma: trends from a Brazilian subset of hematologists. A cross-sectional study. [PDF]

Sao Paulo Med J, 2016
Kerbauy LN, Parmar S, Kutner JM, Gusmão BM, Hamerschlak N.   +4 more
europepmc   +1 more source